Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 18, 2026, inter alia: 1. to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31, 2026; and 2. to consider and recommend final dividend, if any, on equity shares of the Company for the financial year ended March 31, 2026. Further, as per the provisions of Company's Code of Conduct for Prohibition of Insider Trading, trading window for Designated Persons of the Company has been closed from April 1, 2026 and shall open after 48 hours post declaration of financial results by the Company.